Published in World J Stem Cells on April 26, 2014
Nanoengineered biomimetic hydrogels for guiding human stem cell osteogenesis in three dimensional microenvironments. J Mater Chem B Mater Biol Med (2016) 0.79
Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues. Stem Cell Res Ther (2016) 0.77
Impact of electromagnetic fields on stem cells: common mechanisms at the crossroad between adult neurogenesis and osteogenesis. Front Cell Neurosci (2015) 0.77
Cytokine-Rich Adipose Tissue Extract Production from Water-Assisted Lipoaspirate: Methodology for Clinical Use. Biores Open Access (2016) 0.75
Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration. Stem Cell Res Ther (2017) 0.75
Matrix elasticity directs stem cell lineage specification. Cell (2006) 43.00
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell (2008) 18.18
Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell (2004) 16.89
Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol (2007) 16.55
Mesenchymal stem cells in health and disease. Nat Rev Immunol (2008) 11.14
The extracellular matrix: not just pretty fibrils. Science (2009) 8.52
Growth factors, matrices, and forces combine and control stem cells. Science (2009) 8.46
Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation. Science (2013) 6.43
TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science (2005) 5.56
Telomerase activity in human germline and embryonic tissues and cells. Dev Genet (1996) 5.00
Integrin ligands at a glance. J Cell Sci (2006) 4.76
The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol (2010) 4.72
Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone (2003) 4.61
The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med (2013) 4.32
Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol (2000) 4.27
Stem cells, ageing and the quest for immortality. Nature (2006) 3.89
The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells (2007) 3.68
No place like home: anatomy and function of the stem cell niche. Nat Rev Mol Cell Biol (2008) 3.46
Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study. Transplantation (2011) 3.24
Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol (2002) 3.20
Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res (2007) 3.19
Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res (1999) 3.05
The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood (1994) 3.04
Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) (2005) 3.00
Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci (2004) 2.96
A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood (2004) 2.90
Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells (2006) 2.85
SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood (2006) 2.83
Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum (2009) 2.64
Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene (2004) 2.47
O2 regulates stem cells through Wnt/β-catenin signalling. Nat Cell Biol (2010) 2.45
TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc Natl Acad Sci U S A (2011) 2.33
Regulation of integrin activation. Annu Rev Cell Dev Biol (2011) 2.32
Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing. Bone (2005) 2.30
Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng (2012) 2.27
Molecular signature of quiescent satellite cells in adult skeletal muscle. Stem Cells (2007) 2.23
Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone (2006) 2.23
Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood) (2008) 2.23
Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone (2008) 2.19
Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. Biomaterials (2010) 2.17
Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol (2000) 2.15
Role of the extracellular matrix in regulating stem cell fate. Nat Rev Mol Cell Biol (2013) 2.09
Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Miner Res (2007) 1.99
Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. Int J Oral Maxillofac Surg (2009) 1.97
Architecture of human telomerase RNA. Proc Natl Acad Sci U S A (2011) 1.93
Modulation of canonical Wnt signaling by the extracellular matrix component biglycan. Proc Natl Acad Sci U S A (2011) 1.85
Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res (2004) 1.83
White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res (2009) 1.78
Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone (2001) 1.74
The potential of adipose stem cells in regenerative medicine. Stem Cell Rev (2011) 1.74
Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions. Mol Cell Biol (2001) 1.72
Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A (2009) 1.67
Stromal progenitor cells from endogenous adipose tissue contribute to pericytes and adipocytes that populate the tumor microenvironment. Cancer Res (2012) 1.63
Three-dimensional cellular development is essential for ex vivo formation of human bone. Nat Biotechnol (2000) 1.62
The tail of integrin activation. Trends Biochem Sci (2011) 1.62
Extracellular matrix, integrins, and growth factors as tailors of the stem cell niche. Curr Opin Cell Biol (2012) 1.51
Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem Biophys Res Commun (2005) 1.46
Telomerase: central regulator of all of the hallmarks of cancer. Trends Biochem Sci (2013) 1.46
Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? Immunol Cell Biol (2012) 1.43
Lack of telomerase activity in human mesenchymal stem cells. Leukemia (2003) 1.42
Mechanism of dominant-negative telomerase function. Cell Cycle (2009) 1.41
Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther (2008) 1.40
Cytoskeletal and focal adhesion influences on mesenchymal stem cell shape, mechanical properties, and differentiation down osteogenic, adipogenic, and chondrogenic pathways. Tissue Eng Part B Rev (2012) 1.38
The use of mesenchymal stem cells for chondrogenesis. Injury (2008) 1.38
Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Clin Cancer Res (2011) 1.38
Adipose-derived stem cells: characterization and current application in orthopaedic tissue repair. Exp Biol Med (Maywood) (2009) 1.37
Tissue engineering and regenerative medicine: recent innovations and the transition to translation. Tissue Eng Part B Rev (2013) 1.34
Hallmarks of telomeres in ageing research. J Pathol (2007) 1.33
Growth of mesenchymal stem cells on electrospun type I collagen nanofibers. Stem Cells (2006) 1.32
A matter of life and death: self-renewal in stem cells. EMBO Rep (2012) 1.30
Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee (2012) 1.30
Mesenchymal stem cells: Molecular characteristics and clinical applications. World J Stem Cells (2010) 1.27
Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro. J Cell Biochem (1999) 1.26
Primary mesenchymal stem and progenitor cells from bone marrow lack expression of CD44 protein. J Biol Chem (2012) 1.23
Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding large-scale highly functional human mesenchymal stem cells. Stem Cells Dev (2010) 1.22
Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials (2006) 1.22
Inside-out, outside-in, and inside-outside-in: G protein signaling in integrin-mediated cell adhesion, spreading, and retraction. Curr Opin Cell Biol (2012) 1.21
Rescuing replication and osteogenesis of aged mesenchymal stem cells by exposure to a young extracellular matrix. FASEB J (2011) 1.19
Resveratrol rescues SIRT1-dependent adult stem cell decline and alleviates progeroid features in laminopathy-based progeria. Cell Metab (2012) 1.18
Clinical applications of mesenchymal stem cells. Korean J Intern Med (2013) 1.18
Clinical use of bone marrow, bone marrow concentrate, and expanded bone marrow mesenchymal stem cells in cartilage disease. Stem Cells Dev (2012) 1.15
Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity. J Bone Miner Res (2010) 1.14
Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine. Expert Opin Biol Ther (2011) 1.14
Tightly anchored tissue-mimetic matrices as instructive stem cell microenvironments. Nat Methods (2013) 1.14
The concept of mesenchymal stem cells. Regen Med (2006) 1.13
Regulation of vasculogenesis by platelet-mediated recruitment of bone marrow-derived cells. Arterioscler Thromb Vasc Biol (2007) 1.13
Adipose tissue-derived progenitor cells and cancer. World J Stem Cells (2010) 1.12
Matrix-mediated retention of osteogenic differentiation potential by human adult bone marrow stromal cells during ex vivo expansion. Biomaterials (2004) 1.12
The potential of human fetal mesenchymal stem cells for off-the-shelf bone tissue engineering application. Biomaterials (2012) 1.10
Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene. Biochem Biophys Res Commun (2005) 1.10
Mesenchymal stromal cell migration: possibilities to improve cellular therapy. Stem Cells Dev (2011) 1.09
Recruitment of a host's osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic. Tissue Eng Part A (2009) 1.09
Chemotaxis and differentiation of human adipose tissue CD34+/CD31- progenitor cells: role of stromal derived factor-1 released by adipose tissue capillary endothelial cells. Stem Cells (2007) 1.08
The migration of bone marrow-derived non-hematopoietic tissue-committed stem cells is regulated in an SDF-1-, HGF-, and LIF-dependent manner. Arch Immunol Ther Exp (Warsz) (2006) 1.08
Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. J Biomed Mater Res A (2006) 1.07
Telomerase accelerates osteogenesis of bone marrow stromal stem cells by upregulation of CBFA1, osterix, and osteocalcin. J Bone Miner Res (2003) 1.07
The cell surface proteome of human mesenchymal stromal cells. PLoS One (2011) 1.06
Differentiation of synovial CD-105(+) human mesenchymal stem cells into chondrocyte-like cells through spheroid formation. J Cell Biochem (2009) 1.06
Minireview: The stem cell next door: skeletal and hematopoietic stem cell "niches" in bone. Endocrinology (2011) 1.06